Patient and staff experiences with an EHR-Integrated Symptom Management Program (eSyM) in oncology

肿瘤科患者和医护人员使用电子病历整合症状管理程序 (eSyM) 的体验

阅读:2

Abstract

CONTEXT: To bolster integration of electronic patient-reported outcomes (ePROs) into routine practice, a consortium of six cancer centers developed an EHR-integrated electronic symptom management program (eSyM) and deployed it in an institutional randomized stepped-wedge hybrid effectiveness-implementation study involving patients receiving chemotherapy or surgery. OBJECTIVES: We conducted qualitative interviews with patients and staff after implementing eSyM to understand and compare experiences and perceptions regarding the intervention and barriers/facilitators to ePRO usage in routine oncology practice. METHODS: We developed semi-structured interview guides for patients and both clinical and non-clinical staff exposed to eSyM. Questions were informed by the Consolidated Framework for Implementation Research (CFIR). Patients provided consent; a consent waiver was obtained for staff. Interview transcripts were dual-coded and thematically analyzed. RESULTS: From September 2020 to March 2024, 79 staff and 14 patients participated in interviews. Staff and patients held similar beliefs regarding eSyM compatibility, communication, and prioritization. Most perceived that eSyM was easy to use and improved communication, but competing demands impeded regular utilization, and deeper engagement was necessary for sustainability. Discordance emerged in the domains of receptivity and technology. Patients were more receptive to eSyM and to using technology than staff perceived. CONCLUSION: Most patients and staff reported that eSyM added value and was easy to navigate. Staff tended to underestimate patients' receptivity to eSyM. De-prioritization of eSyM could reflect a lack of perceived mutual engagement in or impact from the intervention. Understanding perceived and experienced facilitators and barriers can enable successful implementation of ePRO systems like eSyM to improve cancer care delivery.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。